MedTrace Logo

Prophylactic Intravesical Chemotherapy After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: a Randomized Controlled Trial Between Single Postoperative Dose Versus Maintenance Therapy.

NCT02438865 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2018-09-13

No results posted yet for this study

Summary

This clinical trial is designed to compare the effect of single postoperative intravesical chemotherapy instillation versus maintenance therapy on reducing bladder cancer recurrence after surgery for UTUC.

Conditions

  • Neoplasm, Ureter
  • Neoplasm, Bladder

Interventions

DRUG

Immediate instillation of intravesical chemotherapy-Epirubicin-

DRUG

Maintainance therapy of intravesical chemotherapy-Epirubicin-

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Yasser M. Osman, MD · Urology And Nephrology Center, Mansoura University, Mansoura

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2018-05-01
Completion
2018-05-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02438865 on ClinicalTrials.gov